An Updated Systematic Review and Meta-Analysis on Portable Air Cleaners and Blood Pressure: Recommendations for Users and Manufacturers Publisher Pubmed



Faridi S^{1, 2} ; Allen RW³ ; Brook RD⁴ ; Yousefian F⁵ ; Hassanvand MS^{1, 2} ; Carlsten C⁶ Show Affiliations
Source: Ecotoxicology and Environmental Safety Published:2023

Abstract

Fine particulate matter (PM2.5) air pollution is a leading contributor to the global burden of cardiovascular disease (CVD). One important underlying mechanism is an increase in blood pressure (BP). A growing number of studies have reported a beneficial effect of portable air cleaners (PACs) on systolic and diastolic BP; SBP and DBP. We conducted an updated systematic review and meta-analysis of studies using true versus sham mode filtration reporting the effects on BP. Of 214 articles identified up to February 5, 2023, seventeen (from China, USA, Canada, South Korea and Denmark) enrolling approximately 880 participants (484 female) met the inclusion criteria for meta-analyses. Aside from studies conducted in China, research on PACs and BP has been conducted in relatively low pollution settings. Mean indoor PM2.5 concentrations during the active and sham mode purification were 15.9 and 41.2 µg/m3, respectively. The mean efficiency of PACs against indoor PM2.5 was 59.8 % (ranging from 23 % to 82 %). True mode filtration was associated with a pooled mean difference of − 2.35 mmHg (95 % confidence interval [CI]: − 4.5, − 0.2) and − 0.81 mmHg (95 % CI: − 1.86, 0.24) in SBP and DBP, respectively. After removing the studies with high risk of bias, the magnitude of the pooled benefits on SBP and DBP increased to − 3.62 mmHg (95 % CI: − 6.69, − 0.56) and − 1.35 mmHg (95 % CI: − 2.29, − 0.41), respectively. However, there are several barriers to the use of PACs, specifically in low- and middle-income countries (LMICs), such as the initial purchase cost and filter replacements. There may be several avenues to help overcome these economic burdens and improve cost effectiveness, such as implementing government or other subsidized programs to distribute PACs targeting vulnerable and higher-risk individuals. We propose that environmental health researchers and healthcare providers should be better trained to educate the public regarding the use of PACs to reduce the impacts of PM2.5 on cardiometabolic diseases globally. © 2023 The Authors